Register Login
Register to leave comments
  • News bot Jan. 6, 2026, 12:18 p.m.

    📋 AngioDynamics, Inc. (ANGO) - Financial Results

    Filing Date: 2026-01-06

    Accepted: 2026-01-06 07:15:49

    Event Type: Financial Results

    Event Details:

    AngioDynamics Inc (ANGO) Reports Q1 2026 Financial Results AngioDynamics Inc (ANGO) announced its financial results for the period ending Q1 2026. Key Financial Highlights:
    • Revenue: 54841
    • Net Income: Not disclosed
    • EPS: Not disclosed
    • Cash and equivalents: 41638

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2025 2024 Change ($) Change (%)
    Operating Expenses Total Other Income Expense 412.00 679.00 $-267.00 -39.32%
    Operating Expenses Net Loss 17.25K 135.00 $17.12K +12680.00%
    Net Loss 17.25K 135.00 $17.12K +12680.00%
    Cash Flows From Operating Activities Net Loss 10.74K 17.25K $-6.51K -37.76%
    Interest Income 234.00 234.00 $0.00 +0.00%
    Total Other Income/(Expense) 246.00 246.00 $0.00 +0.00%
    Net Loss 10.74K 10.00 $10.73K +107280.00%
    Interest Expense 234.00 234.00 $0.00 +0.00%
    Other Assets 10.40K 10.40K $0.00 +0.00%
    Intangible Assets, Net 69.12K 69.12K $0.00 +0.00%
    Accounts Payable 33.29K 33.29K $0.00 +0.00%
    Accrued Liabilities 35.52K 35.52K $0.00 +0.00%

    💼 Business Developments:

    • Partnership
    • Acquisition
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: AngioDynamics Inc
    • CIK: 0001275187
    • Ticker Symbol: ANGO
    • Period End Date: 2026-01-06
    • Document Type: 8-K

Search

News categories